Baldwin Celebrates AstraZeneca's Commitment to Extend $35 Cap to New Inhalers
December 13, 2024
December 13, 2024
WASHINGTON, Dec. 13 -- Sen. Tammy Baldwin, D-Wisconsin, issued the following news release:
Today, U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Committee on Health, Education, Labor, and Pensions, celebrated the announcement that AstraZeneca will cap the cost of more of their new inhalers at $35. This announcement comes after Baldwin launched an investigation into the extremely high prices pharmaceutical companies charge for inhalers that 25 million Americans with asthma . . .
Today, U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Committee on Health, Education, Labor, and Pensions, celebrated the announcement that AstraZeneca will cap the cost of more of their new inhalers at $35. This announcement comes after Baldwin launched an investigation into the extremely high prices pharmaceutical companies charge for inhalers that 25 million Americans with asthma . . .